Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice

Cardiac damage is the major limiting factor for the clinical use of doxorubicin (DOX). Preclinical studies indicate that inflammatory effects may be involved in DOX-induced cardiotoxicity. N(ε)-(carboxymethyl) lysine (CML) is suggested to be generated subsequent to oxidative stress, including inflam...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bruynzeel, A M E, Abou El Hassan, M A, Schalkwijk, C, Berkhof, J, Bast, A, Niessen, H W M, van der Vijgh, W J F
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2007
Materias:
Translational Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2360105/
https://ncbi.nlm.nih.gov/pubmed/17325706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603640
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares